Heart risks from Vioxx happen much earlier than believed, says Queen’s researcher (press release)

Breaking News from across the 'net: Soup Companies Battle Over MSG Claims While Deceiving Public Ten U.S. States Now Facing Bankruptcy Dr. Thomas Lodi: Healing Cancer From the Inside Out (video) Phone Calls of American Citizens, Journalists Routinely Intercepted by U.S. Military      See all Breaking News... Get Our FREE Email Newsletter Receive natural health product reviews, recommendations and alerts. Instant download of 20+ free downloadable reports and exclusive interviews. Join over 1.2 million monthly readers. Unsubscribe anytime, email privacy guaranteed Also Posted Today: Summary of Green for Life by Victoria Boutenko Now Available as Free Download from HealthBookSummaries.com The Dangers of High Fructose Corn Syrup Bad Eating Habits Produce Inflammation and Changes in Behavior A Safe May Be the Safest Place for Your Emergency Stash Articles Related to This Article: • Merck litigation strategy - destroy expert witnesses • Leaked documents show Merck knew of Vioxx dangers, yet hid them for years • Merck caught in scandal to bury Vioxx heart attack risks, intimidate scientists and keep pushing dangerous drugs; Vioxx lawsuits now forming

This study is the first to specifically address the question of the timing of cardiovascular risk associated with COX-2 inhibitors such as Vioxx and Celebrex.

Conducted with McGill University Health Centre researcher James Brophy and McGill doctoral student Bin Zhang, the findings will be published on-line today in the Canadian Medical Association Journal.

"A quarter of patients who suffered a heart attack while taking Vioxx did so within two weeks of their first Vioxx prescription," says Prof. Lévesque, of Queen's Department of Community Health and Epidemiology. "This demonstrates that cardiovascular risks from taking Vioxx may occur much earlier than previously believed."

Removed from the market in September 2004 by its manufacturer, Merck, after being linked with increased risk of heart attacks and strokes, Vioxx has recently been at the centre of a number of U.S. lawsuits.

The team's previous study on COX-2 inhibitors, which included Vioxx and Celebrex, evaluated whether there was an increased risk of heart attack while taking these medications. The researchers discovered that this was the case for Vioxx.

The current study, funded by the Canadian Institutes for Health Research (CIHR), examines the timing of the cardiovascular risk associated with Vioxx, Prof. Lévesque explains. Over a three-year period they assessed a group of 30,274 Quebec seniors who had been prescribed Vioxx and had no history of previous heart attacks.

As well as finding that one in four people in the study who suffered a heart attack did so within the first two weeks of taking Vioxx, the researchers discovered that the additional cardiovascular risk actually decreases with longer duration of use. The risk of a heart attack returns to normal within one month of stopping the drug.
Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Merck litigation strategy - destroy expert witnesses • Leaked documents show Merck knew of Vioxx dangers, yet hid them for years • Merck caught in scandal to bury Vioxx heart attack risks, intimidate scientists and keep pushing dangerous drugs; Vioxx lawsuits now forming	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/020093.html Reprinting this article: Non-commercial OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/020093.html">Heart risks from Vioxx happen much earlier than believed, says Queen’s researcher (press release)</a>